Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Predicting clinical progression in multiple sclerosis after 6 and 12 years.

Dekker I, Eijlers AJC, Popescu V, Balk LJ, Vrenken H, Wattjes MP, Uitdehaag BMJ, Killestein J, Geurts JJG, Barkhof F, Schoonheim MM.

Eur J Neurol. 2019 Jan 10. doi: 10.1111/ene.13904. [Epub ahead of print]

PMID:
30629788
2.

What Causes Deep Gray Matter Atrophy in Multiple Sclerosis?

Schoonheim MM, Geurts JJG.

AJNR Am J Neuroradiol. 2019 Jan;40(1):107-108. doi: 10.3174/ajnr.A5942. Epub 2018 Dec 27. No abstract available.

PMID:
30591510
3.

Acid sphingomyelinase: No potential as a biomarker for multiple sclerosis.

Leurs CE, Lopes Pinheiro MA, Wierts L, den Hoedt S, Mulder MT, Eijlers AJC, Schoonheim MM, Balk LJ, Uitdehaag BMJ, Killestein J, de Vries HE.

Mult Scler Relat Disord. 2019 Feb;28:44-49. doi: 10.1016/j.msard.2018.11.024. Epub 2018 Nov 30.

PMID:
30553168
4.

Structural network topology relates to tissue properties in multiple sclerosis.

Kiljan S, Meijer KA, Steenwijk MD, Pouwels PJW, Schoonheim MM, Schenk GJ, Geurts JJG, Douw L.

J Neurol. 2019 Jan;266(1):212-222. doi: 10.1007/s00415-018-9130-2. Epub 2018 Nov 22.

5.

Resting-state MEG measurement of functional activation as a biomarker for cognitive decline in MS.

Schoonhoven DN, Fraschini M, Tewarie P, Uitdehaag BM, Eijlers AJ, Geurts JJ, Hillebrand A, Schoonheim MM, Stam CJ, Strijbis EM.

Mult Scler. 2018 Nov 22:1352458518810260. doi: 10.1177/1352458518810260. [Epub ahead of print]

PMID:
30465461
6.

No Plasmatic Proteomic Signature at Clinical Disease Onset Associated With 11 Year Clinical, Cognitive and MRI Outcomes in Relapsing-Remitting Multiple Sclerosis Patients.

Bridel C, Eijlers AJC, van Wieringen WN, Koel-Simmelink M, Leurs CE, Schoonheim MM, Killestein J, Teunissen CE.

Front Mol Neurosci. 2018 Oct 31;11:371. doi: 10.3389/fnmol.2018.00371. eCollection 2018.

7.

Is impaired information processing speed a matter of structural or functional damage in MS?

Meijer KA, van Geest Q, Eijlers AJC, Geurts JJG, Schoonheim MM, Hulst HE.

Neuroimage Clin. 2018;20:844-850. doi: 10.1016/j.nicl.2018.09.021. Epub 2018 Sep 26.

8.

Predicting cognitive decline in multiple sclerosis: a 5-year follow-up study.

Eijlers AJC, van Geest Q, Dekker I, Steenwijk MD, Meijer KA, Hulst HE, Barkhof F, Uitdehaag BMJ, Schoonheim MM, Geurts JJG.

Brain. 2018 Sep 1;141(9):2605-2618. doi: 10.1093/brain/awy202.

PMID:
30169585
9.

Determinants of Cognitive Impairment in Patients with Multiple Sclerosis with and without Atrophy.

Eijlers AJC, Meijer KA, van Geest Q, Geurts JJG, Schoonheim MM.

Radiology. 2018 Aug;288(2):544-551. doi: 10.1148/radiol.2018172808. Epub 2018 May 22.

PMID:
29786489
10.

The value of including thalamic atrophy as a clinical trial endpoint in multiple sclerosis.

Schoonheim MM, Ciccarelli O.

Neurology. 2018 Apr 10;90(15):677-678. doi: 10.1212/WNL.0000000000005279. Epub 2018 Mar 14. No abstract available.

PMID:
29540583
11.

Explaining the heterogeneity of functional connectivity findings in multiple sclerosis: An empirically informed modeling study.

Tewarie P, Steenwijk MD, Brookes MJ, Uitdehaag BMJ, Geurts JJG, Stam CJ, Schoonheim MM.

Hum Brain Mapp. 2018 Jun;39(6):2541-2548. doi: 10.1002/hbm.24020. Epub 2018 Feb 21.

12.

Gray matter networks and cognitive impairment in multiple sclerosis.

Rimkus CM, Schoonheim MM, Steenwijk MD, Vrenken H, Eijlers AJ, Killestein J, Wattjes MP, Leite CC, Barkhof F, Tijms BM.

Mult Scler. 2019 Mar;25(3):382-391. doi: 10.1177/1352458517751650. Epub 2018 Jan 11.

13.

Staging of cortical and deep grey matter functional connectivity changes in multiple sclerosis.

Meijer KA, Eijlers AJC, Geurts JJG, Schoonheim MM.

J Neurol Neurosurg Psychiatry. 2018 Feb;89(2):205-210. doi: 10.1136/jnnp-2017-316329. Epub 2017 Oct 6.

PMID:
28986469
14.

Loss of Functional Connectivity in Patients with Parkinson Disease and Visual Hallucinations.

Hepp DH, Foncke EMJ, Olde Dubbelink KTE, van de Berg WDJ, Berendse HW, Schoonheim MM.

Radiology. 2017 Dec;285(3):896-903. doi: 10.1148/radiol.2017170438. Epub 2017 Sep 27.

PMID:
28952907
15.

Damaged fiber tracts of the nucleus basalis of Meynert in Parkinson's disease patients with visual hallucinations.

Hepp DH, Foncke EMJ, Berendse HW, Wassenaar TM, Olde Dubbelink KTE, Groenewegen HJ, D J van de Berg W, Schoonheim MM.

Sci Rep. 2017 Aug 31;7(1):10112. doi: 10.1038/s41598-017-10146-y.

16.

Agreement of MSmetrix with established methods for measuring cross-sectional and longitudinal brain atrophy.

Steenwijk MD, Amiri H, Schoonheim MM, de Sitter A, Barkhof F, Pouwels PJW, Vrenken H.

Neuroimage Clin. 2017 Jun 30;15:843-853. doi: 10.1016/j.nicl.2017.06.034. eCollection 2017.

17.

Increased connectivity of hub networks and cognitive impairment in multiple sclerosis.

Meijer KA, Eijlers AJC, Douw L, Uitdehaag BMJ, Barkhof F, Geurts JJG, Schoonheim MM.

Neurology. 2017 May 30;88(22):2107-2114. doi: 10.1212/WNL.0000000000003982. Epub 2017 May 3.

PMID:
28468841
18.

Altered eigenvector centrality is related to local resting-state network functional connectivity in patients with longstanding type 1 diabetes mellitus.

van Duinkerken E, Schoonheim MM, IJzerman RG, Moll AC, Landeira-Fernandez J, Klein M, Diamant M, Snoek FJ, Barkhof F, Wink AM.

Hum Brain Mapp. 2017 Apr 21. doi: 10.1002/hbm.23617. [Epub ahead of print]

PMID:
28429383
19.

In-vivo imaging of meningeal inflammation in multiple sclerosis: Presence of evidence or evidence of presence?

Kilsdonk ID, Schoonheim M, Wattjes MP.

Mult Scler. 2017 Jul;23(8):1169-1171. doi: 10.1177/1352458517704924. Epub 2017 Apr 18. No abstract available.

20.

Metabolites predict lesion formation and severity in relapsing-remitting multiple sclerosis.

Klauser AM, Wiebenga OT, Eijlers AJ, Schoonheim MM, Uitdehaag BM, Barkhof F, Pouwels PJ, Geurts JJ.

Mult Scler. 2018 Apr;24(4):491-500. doi: 10.1177/1352458517702534. Epub 2017 Apr 13.

PMID:
28406063
21.

Cognitive impairment in patients with multiple sclerosis is associated with atrophy of the inner retinal layers.

Coric D, Balk LJ, Verrijp M, Eijlers A, Schoonheim MM, Killestein J, Uitdehaag BM, Petzold A.

Mult Scler. 2018 Feb;24(2):158-166. doi: 10.1177/1352458517694090. Epub 2017 Feb 1.

22.

Increased default-mode network centrality in cognitively impaired multiple sclerosis patients.

Eijlers AJ, Meijer KA, Wassenaar TM, Steenwijk MD, Uitdehaag BM, Barkhof F, Wink AM, Geurts JJ, Schoonheim MM.

Neurology. 2017 Mar 7;88(10):952-960. doi: 10.1212/WNL.0000000000003689. Epub 2017 Feb 8.

PMID:
28179464
23.

Functional reorganization is a maladaptive response to injury - Commentary.

Schoonheim MM.

Mult Scler. 2017 Feb;23(2):194-196. doi: 10.1177/1352458516677593. Epub 2016 Dec 8. No abstract available.

PMID:
27932692
24.

Disrupted topological organization of structural and functional brain connectomes in clinically isolated syndrome and multiple sclerosis.

Shu N, Duan Y, Xia M, Schoonheim MM, Huang J, Ren Z, Sun Z, Ye J, Dong H, Shi FD, Barkhof F, Li K, Liu Y.

Sci Rep. 2016 Jul 12;6:29383. doi: 10.1038/srep29383.

25.

Subgenual Cingulate Cortex Functional Connectivity in Relation to Depressive Symptoms and Cognitive Functioning in Type 1 Diabetes Mellitus Patients.

van Duinkerken E, Ryan CM, Schoonheim MM, Barkhof F, Klein M, Moll AC, Diamant M, IJzerman RG, Snoek FJ.

Psychosom Med. 2016 Jul-Aug;78(6):740-9. doi: 10.1097/PSY.0000000000000335.

PMID:
27136504
26.

White Matter Diffusion Changes during the First Year of Natalizumab Treatment in Relapsing-Remitting Multiple Sclerosis.

Wiebenga OT, Schoonheim MM, Hulst HE, Nagtegaal GJ, Strijbis EM, Steenwijk MD, Polman CH, Pouwels PJ, Barkhof F, Geurts JJ.

AJNR Am J Neuroradiol. 2016 Jun;37(6):1030-7. doi: 10.3174/ajnr.A4690. Epub 2016 Mar 10.

27.

Grey Matter Atrophy in Multiple Sclerosis: Clinical Interpretation Depends on Choice of Analysis Method.

Popescu V, Schoonheim MM, Versteeg A, Chaturvedi N, Jonker M, Xavier de Menezes R, Gallindo Garre F, Uitdehaag BM, Barkhof F, Vrenken H.

PLoS One. 2016 Jan 8;11(1):e0143942. doi: 10.1371/journal.pone.0143942. eCollection 2016.

28.

Structural MRI substrates of cognitive impairment in neuromyelitis optica.

Liu Y, Fu Y, Schoonheim MM, Zhang N, Fan M, Su L, Shen Y, Yan Y, Yang L, Wang Q, Zhang N, Yu C, Barkhof F, Shi FD.

Neurology. 2015 Oct 27;85(17):1491-9. doi: 10.1212/WNL.0000000000002067. Epub 2015 Sep 30.

PMID:
26423432
29.

Multi-parametric structural magnetic resonance imaging in relation to cognitive dysfunction in long-standing multiple sclerosis.

Daams M, Steenwijk MD, Schoonheim MM, Wattjes MP, Balk LJ, Tewarie PK, Killestein J, Uitdehaag BM, Geurts JJ, Barkhof F.

Mult Scler. 2016 Apr;22(5):608-19. doi: 10.1177/1352458515596598. Epub 2015 Jul 24.

PMID:
26209593
30.

Network collapse and cognitive impairment in multiple sclerosis.

Schoonheim MM, Meijer KA, Geurts JJ.

Front Neurol. 2015 Apr 14;6:82. doi: 10.3389/fneur.2015.00082. eCollection 2015. Review. No abstract available.

31.

Enhanced axonal metabolism during early natalizumab treatment in relapsing-remitting multiple sclerosis.

Wiebenga OT, Klauser AM, Schoonheim MM, Nagtegaal GJ, Steenwijk MD, van Rossum JA, Polman CH, Barkhof F, Pouwels PJ, Geurts JJ.

AJNR Am J Neuroradiol. 2015 Jun;36(6):1116-23. doi: 10.3174/ajnr.A4252. Epub 2015 Mar 5.

32.

Memory impairment in multiple sclerosis: Relevance of hippocampal activation and hippocampal connectivity.

Hulst HE, Schoonheim MM, Van Geest Q, Uitdehaag BM, Barkhof F, Geurts JJ.

Mult Scler. 2015 Nov;21(13):1705-12. doi: 10.1177/1352458514567727. Epub 2015 Feb 13.

PMID:
25680986
33.

Thalamus structure and function determine severity of cognitive impairment in multiple sclerosis.

Schoonheim MM, Hulst HE, Brandt RB, Strik M, Wink AM, Uitdehaag BM, Barkhof F, Geurts JJ.

Neurology. 2015 Feb 24;84(8):776-83. doi: 10.1212/WNL.0000000000001285. Epub 2015 Jan 23.

PMID:
25616483
34.

Functional connectivity and cognitive decline over 3 years in Parkinson disease.

Olde Dubbelink KT, Schoonheim MM, Deijen JB, Twisk JW, Barkhof F, Berendse HW.

Neurology. 2014 Nov 25;83(22):2046-53. doi: 10.1212/WNL.0000000000001020. Epub 2014 Oct 29.

PMID:
25355821
35.

Functional brain networks: linking thalamic atrophy to clinical disability in multiple sclerosis, a multimodal fMRI and MEG study.

Tewarie P, Schoonheim MM, Schouten DI, Polman CH, Balk LJ, Uitdehaag BM, Geurts JJ, Hillebrand A, Barkhof F, Stam CJ.

Hum Brain Mapp. 2015 Feb;36(2):603-18. doi: 10.1002/hbm.22650. Epub 2014 Oct 8.

PMID:
25293505
36.

Ventral striatum, but not cortical volume loss, is related to cognitive dysfunction in type 1 diabetic patients with and without microangiopathy.

van Duinkerken E, Schoonheim MM, Steenwijk MD, Klein M, IJzerman RG, Moll AC, Heymans MW, Snoek FJ, Barkhof F, Diamant M.

Diabetes Care. 2014 Sep;37(9):2483-90. doi: 10.2337/dc14-0016. Epub 2014 Jun 27.

PMID:
24973436
37.

Structural degree predicts functional network connectivity: a multimodal resting-state fMRI and MEG study.

Tewarie P, Hillebrand A, van Dellen E, Schoonheim MM, Barkhof F, Polman CH, Beaulieu C, Gong G, van Dijk BW, Stam CJ.

Neuroimage. 2014 Aug 15;97:296-307. doi: 10.1016/j.neuroimage.2014.04.038. Epub 2014 Apr 23.

PMID:
24769185
38.

Differential impact of subclinical carotid artery disease on cerebral structure and functioning in type 1 diabetes patients with versus those without proliferative retinopathy.

van Duinkerken E, Ijzerman RG, van der Zijl NJ, Barkhof F, Pouwels PJ, Schoonheim MM, Moll AC, Boerop J, Wessels AM, Klein M, Snoek FJ, Diamant M.

Cardiovasc Diabetol. 2014 Mar 12;13:58. doi: 10.1186/1475-2840-13-58.

39.

Use of a virtual world computer environment for international distance education: lessons from a pilot project using Second Life.

Schoonheim M, Heyden R, Wiecha JM.

BMC Med Educ. 2014 Feb 21;14:36. doi: 10.1186/1472-6920-14-36.

40.

Longitudinal absolute metabolite quantification of white and gray matter regions in healthy controls using proton MR spectroscopic imaging.

Wiebenga OT, Klauser AM, Nagtegaal GJ, Schoonheim MM, Barkhof F, Geurts JJ, Pouwels PJ.

NMR Biomed. 2014 Mar;27(3):304-11. doi: 10.1002/nbm.3063. Epub 2014 Jan 7.

PMID:
24399803
41.

Changes in functional network centrality underlie cognitive dysfunction and physical disability in multiple sclerosis.

Schoonheim MM, Geurts J, Wiebenga OT, De Munck JC, Polman CH, Stam CJ, Barkhof F, Wink AM.

Mult Scler. 2014 Jul;20(8):1058-65. doi: 10.1177/1352458513516892. Epub 2013 Dec 17.

PMID:
24347184
42.

Cognition in MS correlates with resting-state oscillatory brain activity: An explorative MEG source-space study.

Van der Meer ML, Tewarie P, Schoonheim MM, Douw L, Barkhof F, Polman CH, Stam CJ, Hillebrand A.

Neuroimage Clin. 2013 May 13;2:727-34. doi: 10.1016/j.nicl.2013.05.003. eCollection 2013.

43.

Functional brain network analysis using minimum spanning trees in Multiple Sclerosis: an MEG source-space study.

Tewarie P, Hillebrand A, Schoonheim MM, van Dijk BW, Geurts JJ, Barkhof F, Polman CH, Stam CJ.

Neuroimage. 2014 Mar;88:308-18. doi: 10.1016/j.neuroimage.2013.10.022. Epub 2013 Oct 22.

PMID:
24161625
44.

Sex-specific extent and severity of white matter damage in multiple sclerosis: implications for cognitive decline.

Schoonheim MM, Vigeveno RM, Rueda Lopes FC, Pouwels PJ, Polman CH, Barkhof F, Geurts JJ.

Hum Brain Mapp. 2014 May;35(5):2348-58. doi: 10.1002/hbm.22332. Epub 2013 Aug 24.

PMID:
23982918
45.

Cognitive and clinical dysfunction, altered MEG resting-state networks and thalamic atrophy in multiple sclerosis.

Tewarie P, Schoonheim MM, Stam CJ, van der Meer ML, van Dijk BW, Barkhof F, Polman CH, Hillebrand A.

PLoS One. 2013 Jul 31;8(7):e69318. doi: 10.1371/journal.pone.0069318. Print 2013.

46.

Clinical significance of atrophy and white matter mean diffusivity within the thalamus of multiple sclerosis patients.

Benedict RH, Hulst HE, Bergsland N, Schoonheim MM, Dwyer MG, Weinstock-Guttman B, Geurts JJ, Zivadinov R.

Mult Scler. 2013 Oct;19(11):1478-84. doi: 10.1177/1352458513478675. Epub 2013 Mar 4.

PMID:
23459570
47.

MEG network differences between low- and high-grade glioma related to epilepsy and cognition.

van Dellen E, Douw L, Hillebrand A, Ris-Hilgersom IH, Schoonheim MM, Baayen JC, De Witt Hamer PC, Velis DN, Klein M, Heimans JJ, Stam CJ, Reijneveld JC.

PLoS One. 2012;7(11):e50122. doi: 10.1371/journal.pone.0050122. Epub 2012 Nov 14.

48.

Functional segmentation of the hippocampus in the healthy human brain and in Alzheimer's disease.

Zarei M, Beckmann CF, Binnewijzend MA, Schoonheim MM, Oghabian MA, Sanz-Arigita EJ, Scheltens P, Matthews PM, Barkhof F.

Neuroimage. 2013 Feb 1;66:28-35. doi: 10.1016/j.neuroimage.2012.10.071. Epub 2012 Nov 3. Erratum in: Neuroimage. 2013 Dec;83:1109.

PMID:
23128076
49.

Subcortical atrophy and cognition: sex effects in multiple sclerosis.

Schoonheim MM, Popescu V, Rueda Lopes FC, Wiebenga OT, Vrenken H, Douw L, Polman CH, Geurts JJ, Barkhof F.

Neurology. 2012 Oct 23;79(17):1754-61. doi: 10.1212/WNL.0b013e3182703f46. Epub 2012 Sep 26.

PMID:
23019265
50.

Functional plasticity in MS: friend or foe?

Schoonheim MM, Filippi M.

Neurology. 2012 Oct 2;79(14):1418-9. doi: 10.1212/WNL.0b013e31826d602e. Epub 2012 Sep 12. No abstract available.

PMID:
22972649

Supplemental Content

Loading ...
Support Center